United States: CMS Proposes Reporting And Payment Changes In Proposed 2016 Physician Fee Schedule Rule

On July 15, 2015, the Centers for Medicare and Medicaid Services ("CMS") published its Calendar Year ("CY") 2016 Physician Fee Schedule ("PFS") Proposed Rule in the Federal Register. The rule proposes new physician payment and quality monitoring policies; begins implementation of the Medicare Access and CHIP Reauthorization Act of 2015 ("MACRA"), in which Congress scrapped the historic Sustainable Growth Rate (or "SGR") formula and, separately, authorized CMS to implement the Merit-Based Based Incentive Payment System ("MIPS"); and proposes to finalize changes to the Physician Quality Reporting System ("PQRS"), the Physician Value-Based Payment Modifier ("Value Modifier"), and the Medicare Electronic Health Record ("EHR") Incentive Program. Notably, the to-be-developed MIPS program will replace the PQRS and Value Modifier programs in 2019; the first MIPS performance measurement period could begin as early as CY 2017.

Although the proposed rule keeps the existing physician value-based purchasing programs largely in place for the time being, it reinforces the need for physicians to stay abreast of evolving reporting structures and requirements for quality and outcomes-based measures, especially as MIPS rolls out, lest they face significant reductions, or miss out on meaningful increases, in Medicare payment. As one example, under the existing PQRS and Value Modifier programs, Medicare groups of ten or more physicians could face as high as a 6% percentage reduction in their Medicare rates of payment in CY 2017. Moreover, under MIPS, the potential Medicare payment rate percentage adjustments, positive and negative, will increase from 4% in 2019 to 9% in 2022 and subsequent years. Further, physicians should note CMS's intention to increase the volume of their reported quality data that is publicly available to consumers for comparison.

These proposals, as well as certain other proposed changes, are summarized below. Also, see CMS Proposes New Stark Exceptions and Clarifications in Proposed 2016 Physician Fee Schedule Rule, published here, for a description of the proposed rule's changes to physician self-referral regulations. Comments on the proposed rule are due by September 8, 2015.

Select Topics Covered in the 2016 PFS Proposed Rule

  • Physician Quality Reporting System. CY 2016 will be used as the reporting period for the CY 2018 PQRS reductions. Consistent with the 2017 PQRS reduction (to be taken based upon 2015 reported measures), CMS proposes a 2% payment reduction in 2018 for individual eligible providers or group practices that do not satisfactorily report data on PQRS quality measures or, in lieu of reporting, participate in a qualified clinical data registry ("QCDR") in 2016. The 2018 reduction will be the last under PQRS; adjustments thereafter will be governed by MIPS. CMS further proposes the addition and elimination of certain measures, yielding a grand total of 300 measures in the PQRS set for 2016 if all proposals are finalized.
  • Reported Measures and Benchmarks Publicly Available. CMS continues to increase public reporting of individual and group-level PQRS reported measures on the Physician Compare website and proposes to do the same with QCDR measures. In addition, CMS proposes public reporting of benchmarks using the Achievable Benchmark of Care methodology, which is annually calculated based on PQRS performance rates. CMS believes that such benchmarks, to be displayed as a five-star rating, will enable consumers to compare both physician groups and individual physicians.
  • Physician Value-Based Payment Modifier. As in years past, the CY 2018 Value Modifier will be applied based on PQRS participation by group practices and individual providers. CMS will continue to use its quality-tiering methodology for upward, neutral and downward adjustments for all groups and practitioners that successfully report PQRS measures during CY 2016. Beginning with CY 2018, Value Modifiers will be applied to non-physician eligible provider groups (PAs, NPs, CNSs, CRNAs) and solo practitioners; however, such providers will not be subject to downward adjustments. Further, CMS proposes to waive application of the Value Modifier if groups and providers participated in the Pioneer ACO Model, CPCI or another applicable model beginning with the CY 2017 adjustment period. Finally, consistent with CY 2017, the maximum upward and downward adjustment factors remain at 4.0% for groups of 10 or more eligible providers and 2.0% for groups of fewer than ten as well as solo providers (both physicians and non-physicians). The Value Modifier Program will end in CY 2018 and be replaced with MIPS beginning in CY 2019.
  • Medicare EHR Incentive Program. CMS proposes to revise the definition of certified EHR technology such that in order to electronically submit clinical quality measures, EHR technology must be certified according to applicable submission standards issued by the Office of the National Coordinator for Health Information Technology.
  • Medicare Shared Savings Program. CMS proposes to modify specific sections of the Shared Savings Program regulations. Most importantly, CMS allows measure owners to eliminate measures if such owners determine that such measures no longer align with current clinical practice or cause patient harm. Further, CMS clarifies how PQRS-eligible providers participating in ACOs can meet their PQRS reporting requirements when ACOs report quality measures. Finally, CMS proposes to amend the definition of "primary care services" to exclude claims submitted by skilled nursing facilities and to include claims by Electing Teaching Amendment hospitals.
  • Request for Input on MACRA Implementation. CMS seeks input on the implementation of MACRA, including how to structure the physician-focused payment model (MIPS). CMS indicates that it will send out a subsequent Request for Information requesting comments on a broader range of MACRA implementation issues.
  • Other Proposed Rule Changes. CMS proposes other changes to physician reporting and payment mechanisms, including: (i) modifying billing codes for biosimilars; (ii) implementing methodologies to reduce the payment of misvalued CPT codes and phasing in certain RVU reductions, both in accordance with the Protecting Access to Medicare Act of 2014; (iii) tightening up the requirement that, for certain "incident to" services furnished by auxiliary personnel, the billing practitioner must also be the individual who supervises the personnel; and (iv) changing physician opt-out procedures to accord with new statutory requirements enacted by Congress in MACRA.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions